Cargando…
Cellular immunity induced by a recombinant adenovirus- human dendritic cell vaccine for melanoma
BACKGROUND: Human Adenoviral vectors (HAdV) are immunogenic vectors which have been tested in many vaccination and gene therapy settings. Dendritic cells (DC) transduced by genetically engineered HAdV-5 (HAdV-5/DC), are investigational cancer vaccines being tested clinically. We have previously exam...
Autores principales: | Naveh, Hadas Prag, Vujanovic, Lazar, Butterfield, Lisa H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019908/ https://www.ncbi.nlm.nih.gov/pubmed/24829755 http://dx.doi.org/10.1186/2051-1426-1-19 |
Ejemplares similares
-
Adenovirus-engineered human dendritic cells induce natural killer cell chemotaxis via CXCL8/IL-8 and CXCL10/IP-10
por: Vujanovic, Lazar, et al.
Publicado: (2012) -
Dendritic Cell-Based Vaccines Positively Impact Natural Killer and Regulatory T Cells in Hepatocellular Carcinoma Patients
por: Bray, Sarah M., et al.
Publicado: (2011) -
Alpha fetoprotein directly induces a unique pro-inflammatory, IL-2 hyperresponsive phenotype in human natural killer cells
por: Vujanovic, Lazar, et al.
Publicado: (2014) -
Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity
por: Blalock, LeeAnn T., et al.
Publicado: (2012) -
Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma
por: Butterfield, Lisa H., et al.
Publicado: (2019)